Park, Choon Sik
for the ISABELA 1 and 2 Investigators
4 papers on CoChatORCID 0000-0003-2977-0255
Most cited papers
- Verified
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials
Maher, T. M., Ford, P., Brown, K. K., Costabel, U., Cottin, V., Danoff, S. K., Groenveld, I., Helmer, E., Jenkins, R. G., Milner, J., et al. (2023) · JAMA
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research
Cited by 148
- Verified
Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation
Choi, J.-M., Ahn, M.-H., Chae, W.-J., Jung, Y.-G., Park, J.-C., Song, H.-M., Kim, Y.-E., Shin, J.-A., Park, C.-S., Park, J.-W., et al. (2006) · Nature Medicine
Allergic Rhinitis and SensitizationAsthma and respiratory diseases
Cited by 138
- Verified
Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
Lee, J.-U., Chang, H. S., Lee, H. J., Jung, C. A., Bae, D. J., Song, H. J., Park, J. S., Uh, S.-T., Kim, Y. H., Seo, K.-H., et al. (2017) · BMC Pulmonary Medicine
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisIL-33, ST2, and ILC Pathways
Cited by 73
- Verified
Comparison of CPI and GAP models in patients with idiopathic pulmonary fibrosis: a nationwide cohort study
Lee, S. H., Park, J. S., Kim, S. Y., Kim, D. S., Kim, Y. W., Chung, M. P., Uh, S. T., Park, C. S., Park, S. W., Jeong, S. H., et al. (2018) · Scientific Reports
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research
Cited by 50
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free